We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Medical Sciences/Metabolic-associated fatty liver disease and gut microbiota: pathogenetic relationships and therapeutic targets.
PeriodicalsMedical Sciences

Metabolic-associated fatty liver disease and gut microbiota: pathogenetic relationships and therapeutic targets.

Checking your access to this record.

Abstract & Overview

The article presents the characteristics of metabolically associated fatty liver disease (МАFLD) in combination with intestinal microbiota. The risk factors for the development of МАFLD, the importance of the «microbiotaintestine-liver» axis in the progression of fatty liver disease and in the disruption of the intestinal microbiome with the development of intestinal dysbiosis, which leads to metabolic disorders in the body, are revealed. The use of the drug UDHА (Ursis) and coloprotector Zafacol 3D, which are means of pathogenetic therapy in patients with МАFLD and intestinal dysbiosis, is pathogenetically justified.

Cite this record

T.D. Zvyagintseva, A. І. Chernobay (2023). Metabolic-associated fatty liver disease and gut microbiota: pathogenetic relationships and therapeutic targets. Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini, 2023(2), 4–11. https://doi.org/10.15407/internalmed2023.02.004

Copy in another style

Zvyagintseva, T., & Chernobay, A. І. (2023). Metabolic-associated fatty liver disease and gut microbiota: pathogenetic relationships and therapeutic targets. Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini, 2023(2), 4–11. https://doi.org/10.15407/internalmed2023.02.004
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.